NMPA Approval

Urokinase for Injection

Approval Number

国药准字H44020645

Company丽珠集团丽珠制药厂

Registration Date

April 9, 2024

Drug Information

Generic Name

注射用尿激酶

Dosage Form

注射剂

Strength

10万单位

Drug Type

化学药品

Registration Date

April 9, 2024

Company Information

Applicant Company

Company Name丽珠集团丽珠制药厂

Company Address

珠海市金湾区创业北路38号

Manufacturing Company

Company Name丽珠集团丽珠制药厂

Company Address

珠海市金湾区创业北路38号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用尿激酶 - NMPA 批准文号 | MedPath